Crinetics Pharmaceuticals, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value
Crinetics Pharmaceuticals, Inc. (CRNX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value of $126.18 million as of 2026-06-30, per its 10-Q filed 2026-08-03.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Additional Disclosures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue · last filed 2026-08-03
- 2026-06-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $126.18M.
- 2026-03-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $121.56M.
- 2025-12-31: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $237.01M.
- 2025-09-30: Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value $201.91M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value |
|---|---|
| 2026-06-30 | $126.18M 10-Q · filed 2026-08-03 |
| 2026-03-31 | $121.56M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $237.01M 10-K · filed 2026-02-26 |
| 2025-09-30 | $201.91M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $81.27M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $136.42M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $337.65M 10-K · filed 2025-02-27 |
| 2024-09-30 | $356.63M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $288.96M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $341.74M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $209.88M 10-K · filed 2024-02-28 |
| 2023-09-30 | $144.67M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $22.27M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $14.26M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $23.15M 10-K · filed 2023-02-28 |
| 2022-09-30 | $27.76M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $23.99M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $43.37M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $80.91M 10-K · filed 2022-03-30 |
| 2021-09-30 | $41.98M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $33.25M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $18.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $15.93M 10-K · filed 2021-03-30 |
| 2020-09-30 | $19.53M 10-Q · filed 2020-11-06 |
| 2020-06-30 | $24.21M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $18.69M 10-Q · filed 2020-05-08 |
| 2019-12-31 | $42.78M 10-K · filed 2020-03-09 |
| 2019-09-30 | $20.24M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $42.42M 10-Q · filed 2019-08-13 |
| 2019-03-31 | $38.23M 10-Q · filed 2019-05-13 |
| 2018-12-31 | $55.26M 10-K · filed 2019-03-13 |
| 2018-09-30 | $52.02M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $15.23M 10-Q · filed 2018-08-30 |